Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: ADMA Biologics Q3 Adj. EPS $0.16 Beats $0.15 Estimate, Sales $134.224M Beat $130.533M Estimate

Author: Benzinga Newsdesk | November 05, 2025 06:18pm
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 by 6.67 percent. This is a 6.67 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $134.224 million which beat the analyst consensus estimate of $130.533 million by 2.83 percent. This is a 12.00 percent increase over sales of $119.839 million the same period last year.

Posted In: ADMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist